Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lakartidningen|May 21, 2020
[Medicinal products in unauthorised indications]Veronica Arthurson, Karl-Mikael Kälkner, Rolf Gedeborg
Lakartidningen|August 4, 2025
[Aggregated statistics from Swedish health registries has been used for evaluating compliance with a contraindication]Karl-Mikael Kälkner, Anders Sundström, Rickard Ljung
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2006
Prostate displacement kit: reducing the radiation dose to the rectumKarl Mikael Kälkner, Josef Nilsson, Marie Lundell, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 4, 2024
Hoarding of insulin and oral antidiabetics in the first phase of the COVID-19 pandemic: Regulatory actions taken to avoid shortageBjörn Zethelius, Anders Sundström, Kenneth Nordback, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2006
Prostate volume determination: differential volume measurements comparing CT and TRUSKarl Mikael Kälkner, Gregory Kubicek, Josef Nilsson, et al.
Palliative Medicine|December 18, 2009
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II studyBo Lennernäs, Ingela Frank-Lissbrant, Hans Lennernäs, et al.
Acta Oncologica (Stockholm, Sweden)|November 25, 2016
Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boostsMarie Hjälm-Eriksson, Anders Ullén, Hemming Johansson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy?Josef Nilsson, Karl Mikael Kälkner, Lars Berg, et al.
Brachytherapy|February 8, 2007
Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancerKarl Mikael Kälkner, Emil Bengtsson, Simone Eriksson, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acidAnders Ullén, Lena Lennartsson, Ulrika Harmenberg, et al.
Pageof 2